Serum levels of IL-22 in patients with compensated or stable decompensated liver cirrhosis are similar to those in healthy controls, but increase significantly in patients with acute decompensation of liver cirrhosis and acute-on-chronic liver failure (ACLF) [30]. Here, IL22 is linked to acute-on-chronic liver failure.